Intensive Glycemic Control May Ward Off Cardiovascular Events

Share this content:
Intensive Glycemic Control May Ward Off Cardiovascular Events
Intensive Glycemic Control May Ward Off Cardiovascular Events

(HealthDay News) -- Intensive glycemic control appears to reduce cardiovascular events in patients with type 2 diabetes, according to a study published in the June 4 issue of the New England Journal of Medicine.

Rodney Hayward, M.D., a senior research scientist at the VA Center for Clinical Management Research and University of Michigan in Ann Arbor, and colleagues collected follow-up data on 1,791 military veterans enrolled in the Veterans Affairs Diabetes Trial. In that trial, patients with type 2 diabetes were randomly assigned to have their blood glucose strictly controlled or not as tightly controlled.

The glycated hemoglobin in the intensive control group was 6.9, on average. For those on standard care, the glycated hemoglobin average was 8.4, according to the study. Over an average follow-up of almost 10 years, those who had their blood glucose strictly controlled had a significantly lower risk of heart attack, stroke, new or worsening heart failure, or amputation for ischemic gangrene, compared with patients whose blood glucose wasn't as strictly controlled. Strict glycemic control had no effect on overall survival, the researchers noted.

"This finding reinforces the importance of combining good blood sugar control with control of other cardiovascular risk factors for a combined effect, especially controlling cholesterol and blood pressure," Hayward told HealthDay.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »